 fluconazol treatment candidiasi immunocompromis children fluconazol new triazol deriv pilot studi episod candidiasi children patient predispos condit human immunodefici viru infect cancer marrow transplant neonat age malnutrit obstruct uropathi drug mg/kg bodi weight daili patient fungemia due candida parapsilosi increas dosag mg/kg clinic microbiolog success case drug-rel transaminas increas case fluconazol effect altern treatment candidiasi children compar trial necessari optim dosag efficaci